Emerging Technologies towards HIV/AIDS

Emerging infectious diseases represent a grave threat to animal and human populations in terms of their impact on global health, agriculture and the economy. HIV Vaccines developed for emerging infections in animals can protect animal health and prevent transmission of zoonotic diseases to humans. The HIV vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations towards HIV/AIDS.

  • Nanotechnology
  • Stemcell Engineering

Related Conference of Emerging Technologies towards HIV/AIDS

May 16-17, 2018

World Congress on Allergy and Immunotherapy

Osaka, Japan
July 12-13, 2018

5th International Conference on Parasitology

Paris, France
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 13-14, 2018

World Conference on Vaccine and Immunization

Romania
September 13-14, 2018

11th Annual Congress on Immunology & Immunotechnology

Zurich, Switzerland
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 20-21, 2018

Global Meet on Immunology and Molecular Biology

Oslo, Norway
October 19-20, 2018

10th World Congress and Expo on Immunology

Baltimore, USA
October 29-30, 2018

6th International Conference on HIV/AIDS, STDs and STIs

San Francisco, USA
November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland
December 05-06-2018

Conference on Biostatistics and Informatics

Dubai, UAE

Emerging Technologies towards HIV/AIDS Conference Speakers

Recommended Sessions

Related Journals

Are you interested in